127 related articles for article (PubMed ID: 33689795)
21. Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.
Fabbro-Peray P; Zouaoui S; Darlix A; Fabbro M; Pallud J; Rigau V; Mathieu-Daude H; Bessaoud F; Bauchet F; Riondel A; Sorbets E; Charissoux M; Amelot A; Mandonnet E; Figarella-Branger D; Duffau H; Tretarre B; Taillandier L; Bauchet L
J Neurooncol; 2019 Mar; 142(1):91-101. PubMed ID: 30523606
[TBL] [Abstract][Full Text] [Related]
22. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
Lieberman FS; Wang M; Robins HI; Tsien CI; Curran WJ; Werner-Wasik M; Smith RP; Schultz C; Hartford AC; Zhang P; Mehta MP
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):878-886. PubMed ID: 30496882
[TBL] [Abstract][Full Text] [Related]
24. A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme.
Alonso-Basanta M; Fang P; Maity A; Hahn SM; Lustig RA; Dorsey JF
J Neurooncol; 2014 Jan; 116(2):365-372. PubMed ID: 24194293
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress.
Suzuki K; Gerelchuluun A; Hong Z; Sun L; Zenkoh J; Moritake T; Tsuboi K
Neuro Oncol; 2013 Sep; 15(9):1186-99. PubMed ID: 23658321
[TBL] [Abstract][Full Text] [Related]
26. Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma.
Mujumdar P; Kopecka J; Bua S; Supuran CT; Riganti C; Poulsen SA
J Med Chem; 2019 Apr; 62(8):4174-4192. PubMed ID: 30925064
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
Uram Ł; Misiorek M; Pichla M; Filipowicz-Rachwał A; Markowicz J; Wołowiec S; Wałajtys-Rode E
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652556
[TBL] [Abstract][Full Text] [Related]
28. Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.
Grossman SA; Olson J; Batchelor T; Peereboom D; Lesser G; Desideri S; Ye X; Hammour T; Supko JG;
Neuro Oncol; 2008 Apr; 10(2):190-8. PubMed ID: 18287342
[TBL] [Abstract][Full Text] [Related]
29. Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.
Seiz M; Nölte I; Pechlivanis I; Freyschlag CF; Schmieder K; Vajkoczy P; Tuettenberg J
Neurosurg Rev; 2010 Jul; 33(3):375-81; discussion 381. PubMed ID: 20306105
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines.
Kardosh A; Blumenthal M; Wang WJ; Chen TC; Schönthal AH
Cancer Biol Ther; 2004 Jan; 3(1):55-62. PubMed ID: 14726653
[TBL] [Abstract][Full Text] [Related]
31. COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.
Gulyas M; Mattsson JSM; Lindgren A; Ek L; Lamberg Lundström K; Behndig A; Holmberg E; Micke P; Bergman B;
Acta Oncol; 2018 Feb; 57(2):244-250. PubMed ID: 29140138
[TBL] [Abstract][Full Text] [Related]
32. Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial.
Alper AB; Tomlin H; Sadhwani U; Whelton A; Puschett J
Am J Ther; 2006; 13(3):229-35. PubMed ID: 16772765
[TBL] [Abstract][Full Text] [Related]
33. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
Jablonska PA; Diez-Valle R; Pérez-Larraya JG; Moreno-Jiménez M; Idoate MÁ; Arbea L; Tejada S; Garcia de Eulate MR; Ramos L; Arbizu J; Domínguez P; Aristu JJ
PLoS One; 2019; 14(6):e0217881. PubMed ID: 31170245
[TBL] [Abstract][Full Text] [Related]
35. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
Park W; Oh YT; Han JH; Pyo H
J Exp Clin Cancer Res; 2008 Nov; 27(1):66. PubMed ID: 19000324
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of the long-term use of temozolomide for treating newly diagnosed glioblastoma in Germany.
Waschke A; Arefian H; Walter J; Hartmann M; Maschmann J; Kalff R
J Neurooncol; 2018 Jun; 138(2):359-367. PubMed ID: 29468446
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Stupp R; Mason WP; van den Bent MJ; Weller M; Fisher B; Taphoorn MJ; Belanger K; Brandes AA; Marosi C; Bogdahn U; Curschmann J; Janzer RC; Ludwin SK; Gorlia T; Allgeier A; Lacombe D; Cairncross JG; Eisenhauer E; Mirimanoff RO; ;
N Engl J Med; 2005 Mar; 352(10):987-96. PubMed ID: 15758009
[TBL] [Abstract][Full Text] [Related]
38. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Gogas H; Polyzos A; Stavrinidis I; Frangia K; Tsoutsos D; Panagiotou P; Markopoulos C; Papadopoulos O; Pectasides D; Mantzourani M; Middleton M; Vaiopoulos G; Fountzilas G
Ann Oncol; 2006 Dec; 17(12):1835-41. PubMed ID: 16980601
[TBL] [Abstract][Full Text] [Related]
39. The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma.
Vredenburgh JJ; Desjardins A; Reardon DA; Peters KB; Herndon JE; Marcello J; Kirkpatrick JP; Sampson JH; Bailey L; Threatt S; Friedman AH; Bigner DD; Friedman HS
Clin Cancer Res; 2011 Jun; 17(12):4119-24. PubMed ID: 21531816
[TBL] [Abstract][Full Text] [Related]
40. The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care.
Salem A; Hashem SA; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Sughayer M; Mohamad I; Elyan M; Addas A; Al-Hussaini M; Almousa A
Hematol Oncol Stem Cell Ther; 2011; 4(3):116-20. PubMed ID: 21982884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
